Intrathecal Rituximab in progressive MS stopped for insufficient inhibition of CNS inflammation: a randomized, double-blind, placebo-controlled study
MULTIPLE SCLEROSIS JOURNAL(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL(2016)